ARTICLE | Financial News
Cytomyx lists on AIM
May 29, 2001 7:00 AM UTC
Discovery research and functional genomics company Cytomyx (LSE:CYX) completed its IPO on London's AIM market on Tuesday, selling 9.4 million shares at 4p, valuing the company at L7.2 million ($10.3 m...